SBIR Phase I: A radical cost reduction in medical infusion systems

SBIR 第一阶段：大幅降低医用输液系统的成本

• 批准号: 1345506
• 负责人: Jeffrey Holt
• 金额: $ 15万
• 依托单位: Fluonic, Inc.
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-01-01 至 2014-12-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1345506&HistoricalAwards=false
• 关键词: SBIR; Phase; radical; cost; reduction

This Small Business Innovation Research (SBIR) Phase I project will demonstrate the applicability of a flow measurement technology to the development of a low-cost, closed loop infusion pump. Despite decades of industry research into flow measurement technology, today?s infusion systems run entirely open loop, with no capability to measure the flow they deliver, and this shortcoming compromises pump safety and increases costs. The objective of this SBIR is to demonstrate the feasibility of a flow sensor for drug delivery by demonstrating its reliability in the presence of several medications. The program will provide data to show that the industry?s requirements for the accuracy and reliability of a flow sensor is met , and can be applied to next generation closed loop drug delivery systems. The broader impact/commercial potential of this project is the release of a new generation of low-cost, high accuracy pumps. This technology will make it possible to delivery hospital-level infusion accuracy with the cost model of a disposable pump, enabling infusions to move from the hospital to the home setting. Flow measurement will further enable these infusions to be monitored remotely by nurses, and will enable trends in infusion therapy outcomes to be identified by collecting data which is simply not available today. The technology will result in a substantial reduction in the costs associated with medical infusion by reducing hospital stays, reducing equipment and capital costs, reducing nurse hours dedicated to infusion by automating data collection, and improving outcomes. Flow monitoring will create a new standard of care for medical infusion, and in the future infusions will always be performed with this integral safety and data collection technology.

这项小型企业创新研究（SBIR）I阶段项目将证明流动测量技术在低成本，闭环输液泵的开发中的适用性。 尽管数十年来对流量测量技术进行了数十年的研究，但如今的输液系统完全开放循环，没有能力衡量它们提供的流量，这一缺点损害了泵的安全性并提高了成本。 该SBIR的目的是通过在存在几种药物的情况下证明其可靠性来证明流量传感器的可行性。 该计划将提供数据，以表明该行业对流动传感器的准确性和可靠性的要求得到满足，并且可以应用于下一代闭环药物输送系统。 该项目的更广泛的影响/商业潜力是新一代低成本，高精度泵的释放。 这项技术将通过一次性泵的成本模型来交付医院级输液的准确性，从而使输液从医院转移到家庭环境。 流量测量将进一步使这些输注能够由护士远程监测，并可以通过收集今天无法获得的数据来识别输注疗法结果的趋势。 该技术将通过减少住院，降低设备和资本成本，减少用于通过自动化数据收集的注入并改善结果来大大降低与医疗输液相关的成本。 流量监测将为医疗输液创造新的护理标准，将来将始终使用这种积分安全和数据收集技术进行。